The survival probability in allogenic and autologous BMT patients.

Probability of survival in (A) 134 allogeneic BMT recipients who received fluconazole and 131 who received placebo (P = .0018) and (B) 18 autologous BMT recipients who received fluconazole and 17 who received placebo (P = .6). The allogeneic recipients include 213 patients who received HLA-matched grafts and 52 patients who received mismatched grafts. Tick marks represent patients alive at the last follow-up.